Mr Thomas Boon Lam

Mr Thomas Lam became a full-time NHS consultant urological surgeon and honorary senior lecturer at the Department of Urology, Aberdeen Royal Infirmary in 2016. He is majorly interested in robotic radical prostatectomy- prostate cancer, kidney cancer, urinary tract infections and management of lower urinary tract symptoms in males and females. His clinical experience started after he graduated from Leeds School of Medicine on a British Council scholarship in 1997. Mr Lam had basic surgical training in Leeds and moved to the University of Hull Postgraduate Medical Institute for a clinical research fellowship on Surgical Oncology and Tumour Immunology that led to a PhD degree in 2005. He had a specialist training in Urology through the East of Scotland Training Programme in Urology and it involved moving through Aberdeen and Edinburgh and lately focused on academic urology and laparoscopic pelvic oncology. In 2011, Mr Lam became a senior clinical lecturer and honorary consultant urological surgeon at the Academic Urology Unit of the University of Aberdeen on a clinical academic portfolio. His specialisation was in clinical trials, evidence synthesis, guideline development and core outcome set development. He has had over 7 million pounds aggregated grant income as chief investigator, co-applicant and co-chief investigator in some clinical trials and projects funded by the government of the U.K. Mr Lam has over 100 peer-reviewed articles in distinguished journals with Lancet, Lancet Oncology, and European Urology inclusive. He is invited frequently to deliver lectures and teach urological trainees and clinicians at workshops based on his renowned expertise in managing prostate cancer and kidney cancer, in clinical trial methodology, evidence synthesis and clinical guideline development. He belongs to two associations in charge of clinical practice guidelines issuance to urologists globally for the management of prostate cancer and kidney cancer (the European Association of Urology Prostate Cancer Guideline Panel as well as European Association of Urology Kidney Cancer Guideline Panel). He loves outstanding communication, being able to listen, being humble, and respecting patients and colleagues. Diseases, Medical Tests and Treatments • Robotic radical prostatectomy • Prostate cancer • Kidney cancer • Urinary tract infections • Management of lower urinary tract symptoms • Robotic radical prostatectomy • Prostate cancer • Kidney cancer • Urinary tract infections • Management of lower urinary tract symptoms

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2007–2013
   MD · Medicine and Surgery

   Universitat de València

2. 2013–2017
   Residency · Urology

   Universidad de Sevilla

3. 2017–2018
   Fellowship · Subspecialty training

   AP-HP Paris, FR

1. 2017-09–2018-08
   Junior consultant

   Universitat de València Teaching Hospital — Urology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 13 · i10: 8

Selected publications

1. European registry analysis of Urology outcomes

   Mr Thomas Boon Lam, et al. · European Journal of Medicine, 2025

   DOI: 10.4176/euroclin.2025.0 · cited by 60

2. Outcomes of Urology in adults — a multi-centre cohort

   Mr Thomas Boon Lam, et al. · European Journal of Medicine, 2024

   DOI: 10.1523/euroclin.2024.1 · cited by 14

3. European registry analysis of Urology outcomes

   Mr Thomas Boon Lam, et al. · European Journal of Medicine, 2023

   DOI: 10.1571/euroclin.2023.2 · cited by 104

• Patient education Patient guide to Urology 2026-03-23 · 6 min read
• Awareness When should you see a urology? 2026-01-19 · 7 min read